Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.600 USD | +5.96% | +15.11% | -85.28% |
Aug. 14 | Ladenburg Thalmann Downgrades Marinus Pharmaceuticals to Neutral From Buy | MT |
Aug. 13 | Marinus Pharmaceuticals, Inc., Q2 2024 Earnings Call, Aug 13, 2024 |
End-of-day quotes
Compared values
Sector | Change | 5d. change | 1st Jan change | 1-year change | 5-years change | Capi. | ST | MT | LT | ||
---|---|---|---|---|---|---|---|---|---|---|---|
MARINUS PHARMACEUTICALS, INC. | Other Pharmaceuticals | +5.96% | +15.11% | -85.28% | -77.22% | -70.80% | 85.38M |
- Stock Market
- Equities
- MRNS Stock
- Charts Marinus Pharmaceuticals, Inc.
- Relative Strength Chart